Men Against the Beast from Patient-passive to Patient-active Prostate Cancer Intervention

THE DREAD: Prostate Cancer in the U.S.A. Affects aproximately 10 million men 179,300 new cases in 1999 37,000 died from PCa in 1999

Affects aproximately 10 million men

179,300 new cases in 1999

37,000 died from PCa in 1999

Consequences of Treatment: Impotence Incontinence Loss of Libido

Impotence

Incontinence

Loss of Libido

PCa organizations 1987: American Foundation for Urologic Disease 1990: US-TOO 1993: CaP-CURE 1994: American Prostate Society 1996: National Prostate Cancer Coalition

1987: American Foundation for Urologic Disease

1990: US-TOO

1993: CaP-CURE

1994: American Prostate Society

1996: National Prostate Cancer Coalition

Mortality by type of Cancer and Age Yearly rate per 100.000 persons

Yearly rate per 100.000 persons

Prostate and Breast Cancer Mortality by Year Yearly rate per 100.000 persons

Yearly rate per 100.000 persons

Prostate and Breast Cancer Mortality by Race Yearly rate per 100.000 persons

Yearly rate per 100.000 persons

Impotence Research 1982: International Society for Impotence Research 1989: International Meeting of Andrology 1990’s: vacuum devices 1992: NIH Consensus Development Conference on Impotence 1995: European Society of Impotence Research 1995: Alprostadil 1998: Viagra

1982: International Society for Impotence Research

1989: International Meeting of Andrology

1990’s: vacuum devices

1992: NIH Consensus Development Conference on Impotence

1995: European Society of Impotence Research

1995: Alprostadil

1998: Viagra

Scientific Meetings on Prostate Cancer

NCI Appropriations 1980-1999

Compare: NCI Research dollars by type of cancer

Cancer is incurable, but avoidable Cancer is inevitable, but treatable/curable Prevention So let’s work in So let’s work in Treatment/cure Life-style Regulation Regulatory perspective Survivorship perspective